glp-1 news september 30 2025 weight loss drugs leave users low on key nutrients, study finds GLP-1 - 9/4/2025
Description
5 mg vial + 2 mL bacteriostatic water Step 1 concentration
Advertising on our site helps support our mission
Nausea affects up to 20% of semaglutide users and is the most common reason people discontinue treatment (Alhazmi & le Roux 2026, Frontiers in Endocrinology)
Stice et al., 2008
Goldman Sachs Research estimates that GLP-1 obesity drug prescriptions could reach 30 million Americans by 2028 if coverage barriers are resolved, representing USD 150+ billion in additional annual market potential beyond current diabetes-only prescribing
Whether youre navigating perimenopause, menopause, or post-menopause, GLP-1s can be a powerful tool to help you feel like yourself again
